Prof Jimena Gorfinkiel

UK-AMOR is a new High End Computing consortium working in the general area of atomic, molecular and optical physics. Processes to be investigated using supercomputing resources will comprise: the interaction of atoms and molecules with light including intense light source, electron collisions with atoms, ions and molecules and ultracold chemistry.

This H2020 Twinning project ‘Achievement of Excellence in Electron Processes for Future Technologies’ (ELEvaTE) is aimed at advancing the excellence of the Electron and Plasma Physics Laboratory (EPPL) in the Faculty of Mathematics Physics and Informatics, Comenius University in Bratislava such that it becomes a centre of international excellence and an exemplar for other Slovakian HEI while furthering the Strategy for Smart Specialization of the Slovak Republic. The goal of the ELEvaTE is to provide the EPPL opportunity to learn from partners to achieve ambition of creating a centre of excellence. ELEvaTE will twin EPPL with the Molecular Physics Group at the Open University (OU) in United Kingdom and Nano-Bio-Group at the Institute for Ion Physics and Applied Physics at the University of Innsbruck (UI). The OU is exceptional in results dissemination and the UI combines research with enterprise (e.g. ‘spin out’ company Ionicon, world's leading producer of PTRMS), both are exemplars of ‘widening participation and gender sensitive research’ and are strong in preparing IPR.

We will develop new capability within time-dependent R-matrix theory (RMT) for ultra-fast atomic and molecular processes in general ultra-short light fields. This continues the development of atomic and molecular R-matrix codes initiated as part of the UK-RAMP HPC grant and continued under a number of dCSE and eCSE projects, in a collaboration between QUB and the OU. The work proposed here is aimed at: (i) enabling the description of the interaction of arbitrarily polarized light with atoms and molecules; (ii) fully implementing the treatment of molecules in the TD codes. This work will require significant developments to both the RMT and the UKRmol+ suites.